Tag archive for ‘Teva’
Jewish Business News On Monday, September 11th, 2017

Israeli Troubled Teva Appoints Kare Schultz CEO

  Teva‘s share price is up by more than 8% on the Tel Aviv Stock Exchange after the Israeli pharmaceutical company Named its new Kare Schultz as President and Chief Executive Officer. Kare Schultz, More...

Jewish Business News On Sunday, August 20th, 2017

Teva Launches Generic Testosterone Boost Treatment

Teva Pharmaceutical Industries Ltd. today announced the launch of generic Axiron (testosterone) topical solution CIII, 30 mg/1.5 mL, in the US. Testosterone topical solution CIII is a prescription medicine used More...

Jewish Business News On Thursday, August 3rd, 2017

Teva Wiped Out $6.1 Billion and Cut Forecasts for 2017

Teva Pharmaceutical Industries said on Thursday it would continue to pursue a breach of contract suit against the former owners of its Rimsa plant in Mexico after the Supreme Court of the State of New York rejected More...

Jewish Business News On Sunday, May 7th, 2017

Teva and Active Biotech Announce CONCERTO Trial of Laquinimod Trial Fails

   Teva Pharmaceutical Industries Ltd. and its partner Active Biotech reported on Friday that the CONCERTO trial of its ethical drug laquinimod in patients with relapsing-remitting multiple sclerosis (RRMS) More...

Shai Genish On Wednesday, February 8th, 2017

Israel Police Investigate Teva Bribery Allegations

  Teva bribery: Israeli police’s National Fraud Investigation Unit have opened an investigation against Teva Pharmaceutical Industries after it reached a settlement with US authorities over charges it had More...

Jewish Business News On Tuesday, February 7th, 2017

Teva CEO Erez Vigodman Unexpectedly Resigns Effective Immediately

Teva : L-R Erez Vinograd, Yitzhak Peterburg Israeli generic drugmaker Teva Pharmaceutical Industries Ltd announced last night that Teva CEO Erez Vigodman has resigned effective immediately. The company said it More...

Jewish Business News On Thursday, November 10th, 2016

Leading Israeli Women Honored at NYSE

  For Public Relations and Marketing use only. Not for any additional use unless a written permission granted by SA PRO, Inc. As part of the 10th annual Israel Day at the New York Stock Exchange, the America More...

Jewish Business News On Tuesday, September 20th, 2016

Teva Buys Rights to Regeneron Chronic Pain Drug for $250 Million

Teva Pharmaceutical Industries  and Regeneron Pharmaceuticals. today announced an agreement to develop and commercialize pain drug fasinumab, Regeneron’s investigational NGF antibody in Phase 3 clinical development More...

AAI Letter to the FTC: Generic Pharmaceutical Merger TEVA and ALLERGAN Will Eliminate Important Competition

In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns raised by the proposed merger of generic pharmaceutical More...

Jewish Business News On Wednesday, November 25th, 2015

Teva Pharmaceuticals Licenses Migraine Treatment Candidates

  Teva Pharmaceutical Industries Ltd. and UK-based Heptares Therapeutics, a subsidiary of Tokyo-based Sosei Group have announced a licensing of its migraine treatment candidates. Under the agreement Teva More...

Email:

Delivered by FeedBurner